These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 21549569)

  • 21. Thiazole, thio and semicarbazone derivatives against tropical infective diseases: Chagas disease, human African trypanosomiasis (HAT), leishmaniasis, and malaria.
    Scarim CB; Jornada DH; Machado MGM; Ferreira CMR; Dos Santos JL; Chung MC
    Eur J Med Chem; 2019 Jan; 162():378-395. PubMed ID: 30453246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of trypanosomiasis and leishmaniasis.
    Barrett MP; Croft SL
    Br Med Bull; 2012; 104(1):175-96. PubMed ID: 23137768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diamidines as antitrypanosomal, antileishmanial and antimalarial agents.
    Werbovetz K
    Curr Opin Investig Drugs; 2006 Feb; 7(2):147-57. PubMed ID: 16499285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel compounds to combat trypanosomatid infections: a medicinal chemical perspective.
    González M; Cerecetto H
    Expert Opin Ther Pat; 2011 May; 21(5):699-715. PubMed ID: 21428846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of HIV infection on tropical diseases.
    Harms G; Feldmeier H
    Infect Dis Clin North Am; 2005 Mar; 19(1):121-35, ix. PubMed ID: 15701550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amebiasis and trypanosomiasis.
    Richman TB; Kerdel FA
    Dermatol Clin; 1989 Apr; 7(2):301-11. PubMed ID: 2504524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An Overview on Target-Based Drug Design against Kinetoplastid Protozoan Infections: Human African Trypanosomiasis, Chagas Disease and Leishmaniases.
    Kourbeli V; Chontzopoulou E; Moschovou K; Pavlos D; Mavromoustakos T; Papanastasiou IP
    Molecules; 2021 Jul; 26(15):. PubMed ID: 34361781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiparasitic nitroimidazoles. 1. Some 2-styryl-5-nitroimidazoles.
    Ross WJ; Jamieson WB; McCowen MC
    J Med Chem; 1972 Oct; 15(10):1035-40. PubMed ID: 4341747
    [No Abstract]   [Full Text] [Related]  

  • 29. Retrospective Review of Chromane Analogues as Anti-protozoal Leads: A Decade's Worth of Evolution.
    Jadhav SR; Karan Kumar B; Joshi RP; Suryakant CK; Chandu A; Muzaffar-Ur-Rehman M; Khetmalis YM; Nandikolla A; Murugesan S; Chandra Sekhar KVG
    Curr Top Med Chem; 2023; 23(9):713-735. PubMed ID: 36786146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potent antiprotozoal activity of a novel semi-synthetic berberine derivative.
    Bahar M; Deng Y; Zhu X; He S; Pandharkar T; Drew ME; Navarro-Vázquez A; Anklin C; Gil RR; Doskotch RW; Werbovetz KA; Kinghorn AD
    Bioorg Med Chem Lett; 2011 May; 21(9):2606-10. PubMed ID: 21474310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tissue and blood protozoa including toxoplasmosis, Chagas disease, leishmaniasis, Babesia, Acanthamoeba, Balamuthia, and Naegleria in solid organ transplant recipients- Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.
    La Hoz RM; Morris MI;
    Clin Transplant; 2019 Sep; 33(9):e13546. PubMed ID: 30900295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metal-based drugs for malaria, trypanosomiasis and leishmaniasis: recent achievements and perspectives.
    Navarro M; Gabbiani C; Messori L; Gambino D
    Drug Discov Today; 2010 Dec; 15(23-24):1070-8. PubMed ID: 20974285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening Marine Natural Products for New Drug Leads against Trypanosomatids and Malaria.
    Álvarez-Bardón M; Pérez-Pertejo Y; Ordóñez C; Sepúlveda-Crespo D; Carballeira NM; Tekwani BL; Murugesan S; Martinez-Valladares M; García-Estrada C; Reguera RM; Balaña-Fouce R
    Mar Drugs; 2020 Mar; 18(4):. PubMed ID: 32244488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Flavonoids as efficient scaffolds: Recent trends for malaria, leishmaniasis, Chagas disease, and dengue.
    Boniface PK; Ferreira EI
    Phytother Res; 2019 Oct; 33(10):2473-2517. PubMed ID: 31441148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of Protein-Protein Interactions: New Options for Developing Drugs against Neglected Tropical Diseases.
    Berg T
    Angew Chem Int Ed Engl; 2017 Sep; 56(40):12048-12050. PubMed ID: 28766862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Infectious tropical diseases and modern travel].
    Mohr W
    Munch Med Wochenschr; 1966 Jan; 108(3):151-6. PubMed ID: 6013551
    [No Abstract]   [Full Text] [Related]  

  • 37. Coinfection with HIV and tropical infectious diseases. I. Protozoal pathogens.
    Karp CL; Auwaerter PG
    Clin Infect Dis; 2007 Nov; 45(9):1208-13. PubMed ID: 17918086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Further Investigations of Nitroheterocyclic Compounds as Potential Antikinetoplastid Drug Candidates.
    García-Estrada C; Pérez-Pertejo Y; Domínguez-Asenjo B; Holanda VN; Murugesan S; Martínez-Valladares M; Balaña-Fouce R; Reguera RM
    Biomolecules; 2023 Apr; 13(4):. PubMed ID: 37189384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biological evaluation of glycosyl-isoindigo derivatives against the pathogenic agents of tropical diseases (malaria, Chagas disease, leishmaniasis and human African trypanosomiasis).
    Bouchikhi F; Anizon F; Brun R; Moreau P
    Bioorg Med Chem Lett; 2011 Nov; 21(21):6319-21. PubMed ID: 21937228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiprotozoal agents: How have they changed over a decade?
    Fernandes VS; da Rosa R; Zimmermann LA; Rogério KR; Kümmerle AE; Bernardes LSC; Graebin CS
    Arch Pharm (Weinheim); 2022 Feb; 355(2):e2100338. PubMed ID: 34661935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.